BRAMBLES LIMITED (BXB)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BXB

BXB - BRAMBLES LIMITED

FNArena Sector : Transportation & Logistics
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 1.44
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Brambles is an Australian supply-chain logistics company operating in more than 50 countries. It provides unit-load equipment, pallets, crates and containers to the global transport sector. It first listed on the Australian Securities Exchange in 1954.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$20.78

14 Apr
2025

-0.120

OPEN

$20.97

-0.57%

HIGH

$21.09

2,401,483

LOW

$20.74

TARGET
$21.242 2.2% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
ACE . AIZ . AQZ . AVD . AZJ . CLX . ERD . KLS . KSC . LAU . NTD . QAN . QUB . SLH . SPZ . SST . THL . WTC . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
BXB: 1
Title FY25
Forecast
FY26
Forecast
EPS (cps) 94.2 xxx
DPS (cps) 61.2 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 22.1 xxx
Dividend Yield 2.9% xxx
Div Pay Ratio(%) 65.0% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 5.34%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.57

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 11/09 - ex-div 28.90c (franking 35%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx85.5
DPS All xxxxxxxxxxxxxxx52.0
Sales/Revenue xxxxxxxxxxxxxxx9,988.6 M
Book Value Per Share xxxxxxxxxxxxxxx347.0
Net Operating Cash Flow xxxxxxxxxxxxxxx2,753.6 M
Net Profit Margin xxxxxxxxxxxxxxx11.92 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx26.03 %
Return on Invested Capital xxxxxxxxxxxxxxx14.71 %
Return on Assets xxxxxxxxxxxxxxx8.57 %
Return on Equity xxxxxxxxxxxxxxx26.03 %
Return on Total Capital xxxxxxxxxxxxxxx17.55 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx400.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx234 M
Long Term Debt xxxxxxxxxxxxxxx3,720 M
Total Debt xxxxxxxxxxxxxxx3,954 M
Goodwill - Gross xxxxxxxxxxxxxxx278 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx169 M
Price To Book Value xxxxxxxxxxxxxxx4.19

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1,753.6 M
Capex % of Sales xxxxxxxxxxxxxxx17.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx7,969 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx490 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx227 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

21/02/2025

1

Outperform

$21.85

5.15%

Macquarie highlights Brambles' US business recorded 2% revenue growth from new business wins, the first in a number of years which is an important systemic sign of the improvement in business.

Improved capex efficiency (including in Serialisation) was highlighted as a further positive in the 1H25 result.

On the negative side, the broker notes the group is struggling the last of the extreme US supply chain dislocation, with excess pallet inventory expected to be absorbed by late-FY25.

The broker lowered FY25-26 EPS forecasts by -0.3% and -1.0% respectively.  Target price rises to $21.85 from $21.20 on adjustments to capex profile. Outperform maintained.

FORECAST
Macquarie forecasts a full year FY25 dividend of 56.84 cents and EPS of 91.40 cents.
Macquarie forecasts a full year FY26 dividend of 59.91 cents and EPS of 100.92 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

07/04/2025

3

Neutral

$19.80

-4.72%

Following two years of operating leverage improvement and free cash flow, Jarden is now assessing the sustainability of these factors for Brambles' outlook to FY28.

The broker believes it is unclear if improvements have been driven by factors exogenous to the company or structural changes.

The broker's current forecasts lag consensus but Jarden reckons it is too early to consider upgrades. Among the metrics it will be closely watching are drivers of operating leverage in FY26-28, contributors to free cash flow and factors driving the overall outlook.

Neutral rating. Target unchanged at $19.80.

FORECAST
Jarden forecasts a full year FY25 dividend of 37.70 cents and EPS of 93.24 cents.
Jarden forecasts a full year FY26 dividend of 40.20 cents and EPS of 103.38 cents.

BXB STOCK CHART